Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

A natural protein could revolutionize cancer treatments by facilitating drug absorption into cells. Researchers have ...

Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging gram-negative pathogens without relying ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...

The pair come out of FIU’s Brain, Behavior and the Environment Lab, led by Tomás R. Guilarte, which focuses on uncovering the ...

Abstracts for oral and poster presentations are now being accepted for the 2025 Western Regional Meeting. The meeting will take place October 25–28 at the Signia by Hilton Hotel in San Jose, ...

"They can specify this research goal using natural language, and the AI co-scientist will propose ... its artificial intelligence-powered drug discovery engine and advance its pipeline.

Value Nerve Injury IndicationsTORONTO and HAIFA, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a ...

Debiopharm Research & Manufacturing S.A. (Debiopharm, a Swiss-based global biopharmaceutical company aiming to cure cancer and ...